News Truxima, world's first cancer drug biosimilar approved in Eu... Roche's top seller faces rival four years after patent expiry
News Mylan challenges Amgen's Neulasta in US Mylan and Biocon file biosimilar of white blood cell booster
News EU drug regulators concerned about Brexit impact European regulators concerned over impact of EMA move.
News Enbrel unlikely to face Novartis rival until 2018 Amgen arguing that US patent will last until 2029.
News J&J to "price responsibly", says CEO post Trump meeting Gorsky promises "transparency report" on pricing.
News As rituximab biosimilars close in, Roche showcases Gazyva su... Roche faces competition against its blockbuster haematology drug
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
